Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
23andMe Holding Co. - Common Stock
(NQ:
ME
)
2.500
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
11
Open
2.500
Bid (Size)
2.480 (100)
Ask (Size)
3.000 (1)
Prev. Close
2.500
Today's Range
2.500 - 2.500
52wk Range
2.480 - 16.52
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
23andMe Launches New Genetic Report on Osteoporosis
January 31, 2025
Provides 23andMe+ Premium members with insight into their likelihood of developing osteoporosis based on thousands of genetic variants
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Special Committee Announces Exploration of Strategic Alternatives
January 28, 2025
From
23andMe, Inc.
Via
GlobeNewswire
Performance
YTD
-29.58%
-29.58%
1 Month
-31.32%
-31.32%
3 Month
-46.92%
-46.92%
6 Month
-63.86%
-63.86%
1 Year
-83.76%
-83.76%
More News
Read More
23andMe Reports Third Quarter Fiscal Year 2025 Financial Results
January 28, 2025
From
23andMe, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
Earnings Outlook For 23andMe Holding
November 11, 2024
Via
Benzinga
Deal Dispatch: Lovely Day To Sell Guinness? Plus, 23andMe To Rid Lineage Of Lemonaid
January 25, 2025
Via
Benzinga
23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology
January 08, 2025
From
23andMe, Inc.
Via
GlobeNewswire
Want $500 of Reliable Dividend Income in 2025? Invest $5,040 in These 3 Ultra-High-Yield Stocks.
December 31, 2024
Via
The Motley Fool
The Shake-Up at Intel
December 05, 2024
Via
The Motley Fool
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
November 20, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
November 12, 2024
Via
Benzinga
23andMe Reports Second Quarter Fiscal Year 2025 Financial Results
November 12, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future
November 11, 2024
From
23andMe, Inc.
Via
GlobeNewswire
CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
November 07, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe to Report Q2 FY2025 Financial Results
November 07, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Regains Compliance With Nasdaq Listing Requirements
October 30, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Appoints Three New Independent Directors to Board
October 29, 2024
From
23andMe, Inc.
Via
GlobeNewswire
ASML's Latest Chapter in the Semiconductor Story
October 22, 2024
Via
The Motley Fool
23andMe Introduces New Feature Helping African Americans Trace Their Roots to Post Slavery Communities in the South
October 17, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Author Alok Sama on OpenAI, Bubbles, and When to Sell
October 16, 2024
Via
The Motley Fool
23andMe Announces Completion of 1-for-20 Reverse Stock Split
October 16, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Announces 1-for-20 Reverse Stock Split
October 11, 2024
From
23andMe, Inc.
Via
GlobeNewswire
23andMe Announces Mathew Knowles as New Brand Ambassador
October 08, 2024
From
23andMe, Inc.
Via
GlobeNewswire
Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants
October 02, 2024
Via
Benzinga
Topics
Data Breach
Exposures
Information Security
12 Health Care Stocks Moving In Friday's After-Market Session
September 27, 2024
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.